The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Mooney, John D ^a,b   Weir, Amanda ^a,c   McMenamin, Jim ^a   Ritchie, Lewis D ^d   Macfarlane, Tatania V ^d   Simpson, Colin R ^d   Ahmed, Syed ^e   Robertson, Chris ^a,c   Clarke, Stuart C ^f,g  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b Dorset and Somerset Health Protection Unit   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^f Scottish Meningococcus and Pneumococcus Reference Laboratory   (United Kingdom)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; BACTERIAL VACCINE; VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA COLLECTION METHOD; DRUG EFFICACY; DRUG RESPONSE; ELDERLY CARE; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK REDUCTION; SCREENING TEST; SEX DIFFERENCE; STREPTOCOCCUS INFECTION; UNITED KINGDOM; VACCINATION; WINTER; COMPARATIVE STUDY; HEALTH SURVEY; SEASON;

AGED; BACTERIAL VACCINES; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SCOTLAND; SEASONS; VACCINATION; VACCINES, CONJUGATE;

EID: 44149125077     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-53     Document Type: Article

References (45)

1. Fedson DS Scott JA The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known Vaccine 1999, 17(Suppl 1):S11-8 10.1016/S0264-410X(99)00122-X 10471174
2. Kyaw MH Christie P Clarke SC Mooney JD Ahmed S Jones IG Campbell H Invasive pneumococcal disease in Scotland, 1999-2001: Use of record linkage to explore associations between patients and disease in relation to future vaccination policy Clin Infect Dis 2003, 37(10):1283-1291 10.1086/379016 14583860
3. Redelings MD Sorvillo F Simon P A population-based analysis of pneumococcal disease mortality in California, 1989-1998 Public Health Rep 2005, 120(2):157-164 1497698 15842117
4. Jefferson T Demicheli V Polysaccharide pneumococcal vaccines BMJ (Clinical research ed 2002, 325(7359):292-293 1123818 12169492 10.1136/ bmj.325.7359.292
5. Mulholland K Strategies for the control of pneumococcal diseases Vaccine 1999, 17(Suppl 1):S79-84 10.1016/S0264-410X(99)00112-7 10471187
6. Smit P Oberholzer D Hayden-Smith S Koornhof HJ Hilleman MR Protective efficacy of pneumococcal polysaccharide vaccines Jama 1977, 238(24):2613-2616 10.1001/jama.238.24.2613 21973
7. Conaty S Watson L Dinnes J Waugh N The effectiveness of pneumococcal polysaccharide vaccines in adults: A systematic review of observational studies and comparison with results from randomised controlled trials Vaccine 2004, 22(23-24):3214-3224 10.1016/j.vaccine.2003.08.050 15297076
8. Sisk JE Moskowitz AJ Whang W Lin JD Fedson DS McBean AM Plouffe JF Cetron MS Butler JC Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people Jama 1997, 278(16):1333-1339 10.1001/jama.278.16.1333 9343464
9. Evers SM Ament AJ Colombo GL Konradsen HB Reinert RR Sauerland D Wittrup-Jensen K Loiseau C Fedson DS Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: An update for 10 Western European countries Eur J Clin Microbiol Infect Dis 2007, 26(8):531-540 10.1007/s10096-007-0327-z 17570001
10. Dear K Holden J Andrews R Tatham D Vaccines for preventing pneumococcal infection in adults Cochrane database of systematic reviews (Online) 2003, CD000422 14583920
11. CMO Scotland Scottish Executive Health Department (2003): Pneumococcal vaccine for those aged 65 and over 2003-04 [SEHD/CMO(2003)9] http://www.sehd.scot.nhs.uk/cmo/CMO(2003)09.pdf
12. Salisbury DM Begg NT Department of Health (2006): Immunisation against infectious disease - "The Green Book" - Chapter 25 Pneumococcal Disease http://www.dh.gov.uk/en/Publichealth/ Healthprotection/Immunisation/Greenbook/DH_4097254
13. CMO Scotland Scottish Executive Health Department (2006): Planned changes to the routine childhood immunisation programme [SEHD/ CMO(2006)9] http://www.sehd.scot.nhs.uk/cmo/CMO(2006)09.pdf
14. GRO Scotland General Register Office for Scotland Statistics Library [population estimates] (Accessed 15/07/05) http://www.gro-scotland.gov.uk/statistics/publications-and-data/ population-estimates/index.html
15. Whitelaw FG Nevin SL Milne RM Taylor RJ Taylor MW Watt AH Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland Br J Gen Pract 1996, 46(404):181-186 1239581 8731627
16. ISD Scotland NHS National Services Scotland, Information and Statistics Division [Vaccinations monitoring/Influenza] (Accessed 12/04/2006). http://www.isdscotland.org/isd/3562.html
17. Womersley J The public health uses of the Scottish Community Health Index (CHI) Journal of public health medicine 1996, 18(4):465-472 9023807
18. Farrington CP Estimation of vaccine effectiveness using the screening method International journal of epidemiology 1993, 22(4):742-746 10.1093/ ije/22.4.742 8225751
19. Broome CV Facklam RR Fraser DW Pneumococcal disease after pneumococcal vaccination: An alternative method to estimate the efficacy of pneumococcal vaccine The New England journal of medicine 1980, 303(10):549-552 6995835
20. Baddour LM Yu VL Klugman KP Feldman C Ortqvist A Rello J Morris AJ Luna CM Snydman DR Ko WC Chedid MB Hui DS Andremont A Chiou CC Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia American journal of respiratory and critical care medicine 2004, 170(4):440-444 10.1164/rccm.200311-1578OC
21. CMO Scotland Scottish Executive Health Department (2004): Pneumococcal Imunisation Programme for 2004-05 [SEHD/CMO(2004)15] http://www.sehd.scot.nhs.uk/cmo/CMO(2004)15.pdf
22. Andrews RM Counahan ML Hogg GG McIntyre PB Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia Vaccine 2004, 23(2):132-138 10.1016/j.vaccine.2004.06.016 15531029
23. Dominguez A Salleras L Fedson DS Izquierdo C Ruiz L Ciruela P Fenoll A Casal J Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: A case-control study Clin Infect Dis 2005, 40(9):1250-1257 10.1086/429236 15825026
24. Fedson DS The clinical effectiveness of pneumococcal vaccination: A brief review Vaccine 1999, 17(Suppl 1):S85-90 10.1016/ S0264-410X(99)00113-9 10471188
25. Gould MI Jones K Analyzing perceived limiting long-term illness using U.K. Census Microdata Social science & medicine (1982) 1996, 42(6):857-869 8778998
26. Fedson DS Pneumococcal vaccination for older adults: The first 20 years Drugs & aging 1999, 15(Suppl 1):21-30 10.2165/ 00002512-199915001-00003 10690792
27. Fedson DS Musher DM Pneumococcal polysaccharide vaccine Vaccines New York, Saunders Plotkin SA, Orenstein WA, Offit PA Fourth 2004, 529-588
28. Smith S Sinclair D Raine R Reeves B Non-randomised designs Health Care Evaluation London, Open University Press First Understanding Public Health Black N, Raine R 2005, 77-84
29. Fedson DS Liss C Precise answers to the wrong question: Prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults Vaccine 2004, 22(8):927-946 10.1016/ j.vaccine.2003.09.027 15161070
30. Kim PE Musher DM Glezen WP Rodriguez-Barradas MC Nahm WK Wright CE Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses Clin Infect Dis 1996, 22(1):100-106 8824973
31. Rubins JB Puri AK Loch J Charboneau D MacDonald R Opstad N Janoff EN Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults The Journal of infectious diseases 1998, 178(2):431-440 9697723
32. Smith A McMenamin J Mooney JD Health Protection Scotland Surveillance Report (Vol 38 No.2004/28): Respiratory Infections [Influenza season 2003/2004] http://www.documents.hps.scot.nhs.uk/ewr/pdf2004/0428.pdf
33. Christenson B Hedlund J Lundbergh P Ortqvist A Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Eur Respir J 2004, 23(3):363-368 10.1183/09031936.04.00063504 15065822
34. Nichol KL The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease Vaccine 1999, 17(Suppl 1):S91-3 10.1016/ S0264-410X(99)00114-0 10471189
35. Rubins JB Janoff EN Pneumococcal disease in the elderly: What is preventing vaccine efficacy? Drugs & aging 2001, 18(5):305-311 10.2165/00002512-200118050-00001 11392439
36. Mangtani P Shah A Roberts JA Validation of influenza and pneumococcal vaccine status in adults based on self-report Epidemiology and infection 2007, 135(1):139-143 10.1017/S0950268806006479
37. Shapiro ED Berg AT Austrian R Schroeder D Parcells V Margolis A Adair RK Clemens JD The protective efficacy of polyvalent pneumococcal polysaccharide vaccine The New England journal of medicine 1991, 325(21):1453-1460 1944423
38. Lexau CA Lynfield R Danila R Pilishvili T Facklam R Farley MM Harrison LH Schaffner W Reingold A Bennett NM Hadler J Cieslak PR Whitney CG Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine Jama 2005, 294(16):2043-2051 10.1001/jama.294.16.2043 16249418
39. Hanlon P Lawder RS Buchanan D Redpath A Walsh D Wood R Bain M Brewster DH Chalmers J Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect' Journal of public health (Oxford, England) 2005, 27(2):199-204 10.1093/pubmed/fdi002 15774571
40. Siriwardena AN Targeting pneumococcal vaccination to high-risk groups: A feasibility study in one general practice Postgraduate medical journal 1999, 75(882):208-212 10715759
41. Butler JC Breiman RF Campbell JF Lipman HB Broome CV Facklam RR Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations Jama 1993, 270(15):1826-1831 10.1001/jama.270.15.1826 8411526
42. Breen D Pneumococcal vaccination programme in over 65s and at-risk groups: The Dumfries and Galloway experience Communicable disease and public health/PHLS 2003, 6(3):228-230 14708273
43. McIntosh ED Conway P Willingham J Hollingsworth R Lloyd A Pneumococcal pneumonia in the UK - how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV) Vaccine 2005, 23(14):1739-1745 10.1016/j.vaccine.2004.08.051 15705480
44. Whitney CG Farley MM Hadler J Harrison LH Bennett NM Lynfield R Reingold A Cieslak PR Pilishvili T Jackson D Facklam RR Jorgensen JH Schuchat A Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine The New England journal of medicine 2003, 348(18):1737-1746 10.1056/NEJMoa022823 12724479
45. Mangtani P Cutts F Hall AJ Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: The state of the evidence The Lancet infectious diseases 2003, 3(2):71-78 10.1016/ S1473-3099(03)00514-0 12560191